Litigation Details for Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2021)

Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2021)

Docket		Date Filed	2021-08-31
Court	District Court, D. Delaware	Date Terminated	2022-10-25
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To	Jennifer L. Hall
Patents	10,010,533; 8,344,006; 8,609,707; 8,791,270; 9,034,908; 9,265,831; 9,572,796; 9,572,797; 9,572,887; 9,579,384; 9,597,397; 9,597,399
Link to Docket	External link to docket

Details for Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC (D. Del. 2021)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-08-31	1	Complaint	.S. Patent Nos. 9,265,831, 9,572,796, 9,572,797, and 10,010,533 (“Slayback Notice Letter Patents”), …of U.S. Patent Nos. 8,609,707, 8,791,270, 9,265,831, 9,572,796, 9,572,797, and 10,010,533 (“the Apotex…expiration of Eagle’s U.S. Patent No. 11,103,483 (“the ’483 patent” or “the Patent-in-Suit”). Case 1:21-cv… 1. This is an action for patent infringement under the patent laws of the United States, Title…declaratory judgment of patent infringement under 28 U.S.C. §§ 2201 and 2202 and the patent laws of the United	External link to document
2022-09-23	107		that issued as U.S. Patent No. 10,010,533, and was filed with the USPTO on February 14, 2017. …33326. II. PATENT-IN-SUIT 5. U.S. Patent No. 11,103,483 (the “’483 patent”), entitled …Admitted Facts patent application that issued as the ’483 patent, was filed with the U.S. Patent and Trademark…currently asserting U.S. Patent No. 11,103,483 (“the ‘483 patent” or “Patent-in- Suit”). …and patents of Drager, such as the ’006 Patent. For example, claims 1-5 of the ’006 Patent disclose	External link to document